Treatment of acute respiratory infections in Slovenian children with ivy leaf extract syrup
Abstract
Background: The ivy leaf extract is a natural substance with secretolytic effect. Its efficacy and safety have been documented in several randomized, double-blind placebo-controlled trials. The aim of our study was to confirm the safety of ivy leaf extract in Slovenian children with acute inflammatory airway disease and to investigate the course of treatment. Methods: 193 children with clinical signs of acute airway disease, aged 2 to 14 years were included in a prospective postmarketing study. At the beginning of the study, 7-day treatment with syrup of ivy leaf extract was started. Results: The treatment was effective in 93.7 % of children, who showed an improvement of clinical symptoms. The proportion of children with productive cough was 43.6 % at first visit and 84.9 % at second visit. Skin allergy as a side effect was reported in one child. Conclusions: The study demonstrated that the treatment with ivy leaf extract is safe in children with acute inflammatory airway disease. The quality of sputum and frequency of cough changed during the treatment, and the majority of physicians and patients estimated that the treatment was more effective than in previous episodes of the disease when they had not received this drug.Downloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
